Fujiyama S - Search Results

1

Changes in the Mean Intrahepatic Target Computed Tomography Attenuation Value During Treatment May Be a Useful New Predictor of the Post-progression Survival Associated with Lenvatinib Treatment.

Muraishi N, Kawamura Y, Kobayashi M, Shindoh J, Kobayashi Y, Okubo S, Iritani S, Fujiyama S, Hosaka T, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ikeda K, Arase Y, Hashimoto M, Yasuda I, Kumada H. Muraishi N, et al. Among authors: fujiyama s. Intern Med. 2022 Apr 1;61(7):951-958. doi: 10.2169/internalmedicine.7589-21. Epub 2021 Sep 11. Intern Med. 2022. PMID: 34511564 Free PMC article.

2

Pathological study on gold impregnation of fat-storing cells in human liver.

Kobayashi Y, Fujiyama S. Kobayashi Y, et al. Among authors: fujiyama s. Acta Pathol Jpn. 1981 Jan;31(1):65-74. doi: 10.1111/j.1440-1827.1981.tb00984.x. Acta Pathol Jpn. 1981. PMID: 7234421

3

Long-Term Outcomes of Hepatitis-C-Infected Patients Achieving a Sustained Virological Response and Undergoing Radical Treatment for Hepatocellular Carcinoma.

Kunimoto H, Ikeda K, Sorin Y, Fujiyama S, Kawamura Y, Kobayashi M, Sezaki H, Hosaka T, Akuta N, Saitoh S, Suzuki F, Suzuki Y, Arase Y, Kumada H. Kunimoto H, et al. Among authors: fujiyama s. Oncology. 2016;90(3):167-75. doi: 10.1159/000443891. Epub 2016 Feb 23. Oncology. 2016. PMID: 26901157

4

Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan.

Akuta N, Kawamura Y, Suzuki F, Saitoh S, Arase Y, Kunimoto H, Sorin Y, Fujiyama S, Sezaki H, Hosaka T, Kobayashi M, Suzuki Y, Kobayashi M, Ikeda K, Kumada H. Akuta N, et al. Among authors: fujiyama s. Hepatol Int. 2016 Jul;10(4):647-56. doi: 10.1007/s12072-016-9729-2. Epub 2016 Apr 13. Hepatol Int. 2016. PMID: 27074850

5

Usefulness and limitations of balloon-occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodules.

Kawamura Y, Ikeda K, Fujiyama S, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H. Kawamura Y, et al. Among authors: fujiyama s. Hepatol Res. 2017 Mar;47(4):338-346. doi: 10.1111/hepr.12754. Epub 2016 Jul 12. Hepatol Res. 2017. PMID: 27249401

6

Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan.

Akuta N, Sezaki H, Suzuki F, Fujiyama S, Kawamura Y, Hosaka T, Kobayashi M, Kobayashi M, Saitoh S, Suzuki Y, Arase Y, Ikeda K, Kumada H. Akuta N, et al. Among authors: fujiyama s. J Med Virol. 2017 Feb;89(2):284-290. doi: 10.1002/jmv.24617. Epub 2016 Jul 6. J Med Virol. 2017. PMID: 27357737

7

Beneficial effect of arterial embolization with warmed miriplatin for multiple hepatocellular carcinoma.

Ikeda K, Kawamura Y, Kobayashi M, Fujiyama S, Sezaki H, Hosaka T, Akuta N, Saitoh S, Suzuki F, Suzuki Y, Arase Y, Kumada H. Ikeda K, et al. Among authors: fujiyama s. Hepatol Res. 2017 Jun;47(7):632-640. doi: 10.1111/hepr.12782. Epub 2016 Sep 21. Hepatol Res. 2017. PMID: 27487085

8

Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection.

Kobayashi M, Suzuki F, Fujiyama S, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kumada H. Kobayashi M, et al. Among authors: fujiyama s. J Med Virol. 2017 Mar;89(3):476-483. doi: 10.1002/jmv.24663. Epub 2016 Aug 23. J Med Virol. 2017. PMID: 27531586 Clinical Trial.

9

Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals.

Akuta N, Kobayashi M, Suzuki F, Sezaki H, Fujiyama S, Kawamura Y, Hosaka T, Kobayashi M, Saitoh S, Suzuki Y, Arase Y, Ikeda K, Kumada H. Akuta N, et al. Among authors: fujiyama s. Oncology. 2016;91(6):341-347. doi: 10.1159/000450551. Epub 2016 Oct 1. Oncology. 2016. PMID: 27694754

10

Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs.

Suzuki F, Suzuki Y, Hosaka T, Sezaki H, Akuta N, Fujiyama S, Kawamura Y, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Mineta R, Suzuki Y, Kumada H. Suzuki F, et al. Among authors: fujiyama s. J Gastroenterol. 2017 May;52(5):641-651. doi: 10.1007/s00535-016-1270-5. Epub 2016 Oct 3. J Gastroenterol. 2017. PMID: 27699721

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

316 results

Search Page